2022

1. Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial

   European Radiology, Vol. 32, Núm. 2, pp. 1320-1329

2. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

   Biomedicines, Vol. 10, Núm. 5

3. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort

   Current Oncology, Vol. 29, Núm. 2, pp. 565-577

4. Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma

   British Journal of Cancer, Vol. 126, Núm. 2, pp. 211-218